20276 results for «»
20276 results
Miriam Bascones
Els Boone
Peter Lepilin
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
Julia Mascherbauer
Dimitrios Tsikaderis
Toni Velikov
Ruse, Bulgaria
EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice....
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions
16 May 2024
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
The Jon DeHaan Foundation rewards another innovative idea!
15 May 2024
The competition for the Jon DeHaan Foundation Award was tough at PCR lnnovators Day 2024, but the A-FLUX Reducer System was crowned the winner.
REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024
15 May 2024
The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.
Vascular robotics: Robocath unveils survey findings on users’ current expectations and future developments
15 May 2024
Judit Andreka
Graz, Austria
Maria Isabel Koerber
Cologne, Germany
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
CTO PCI: Addressing acute no-flow, multivessel challenges and calcified lesions
04 Oct 2024 – From AICT-AsiaPCR 2024
Delve into this comprehensive CTO session, featuring a selection of compelling clinical case submissions from AICT-AsiaPCR 2024. Explore various complex CTO scenarios, including the management of acute no-flow after stenting, multivessel PCI for heavily calcified CTOs, and confronting the calcium conundrum. Gain valuable insights from expert...
Bifurcation and stable CAD - Navigating complex cases with creativity and expertise
04 Oct 2024 – From AICT-AsiaPCR 2024
Immerse yourself in this comprehensive session on bifurcation and stable coronary artery disease (CAD), featuring a selection of compelling clinical case submissions from AICT-AsiaPCR 2024. Explore innovative techniques and strategies for managing complex bifurcation lesions, addressing no-reflow after PCI, and utilizing hemodynamic assessment to guide coronary...
